Exact Sciences Corp (NASDAQ: EXAS) is -31.16% lower on its value in year-to-date trading and has touched a low of $40.62 and a high of $79.62 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EXAS stock was last observed hovering at around $50.73 in the last trading session, with the day’s gains setting it 0.2%.
Currently trading at $50.93, the stock is -20.11% and -22.86% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.14 million and changing 0.39% at the moment leaves the stock -12.88% off its SMA200. EXAS registered -19.74% loss for a year compared to 6-month gain of -1.96%. The firm has a 50-day simple moving average (SMA 50) of $66.0232 and a 200-day simple moving average (SMA200) of $58.45635.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -27.88% loss in the last 1 month and extending the period to 3 months gives it a -13.31%, and is -4.32% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.35% over the week and 4.43% over the month.
Exact Sciences Corp (EXAS) has around 6600 employees, a market worth around $9.43B and $2.69B in sales. Profit margin for the company is -7.95%. Distance from 52-week low is 25.37% and -36.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.75%).
The EPS is expected to shrink by -3.33% this year
859.0 institutions hold shares in Exact Sciences Corp (EXAS), with institutional investors hold 104.05% of the company’s shares. The shares outstanding are 185.08M, and float is at 182.28M with Short Float at 7.71%. Institutions hold 103.00% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 18.18 million shares valued at $767.91 million. The investor’s holdings represent 9.9672 of the EXAS Shares outstanding. As of 2024-06-30, the second largest holder is CAPITAL WORLD INVESTORS with 16.5 million shares valued at $697.18 million to account for 9.0493 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 14.79 million shares representing 8.1099 and valued at over $624.81 million, while FMR LLC holds 7.4714 of the shares totaling 13.62 million with a market value of $575.62 million.
Exact Sciences Corp (EXAS) Insider Activity
The most recent transaction is an insider purchase by Conroy Kevin T, the company’s President and CEO. SEC filings show that Conroy Kevin T bought 19,500 shares of the company’s common stock on Nov 13 ’24 at a price of $51.35 per share for a total of $1.0 million. Following the purchase, the insider now owns 1.07 million shares.
Exact Sciences Corp disclosed in a document filed with the SEC on Oct 08 ’24 that Baranick Brian (EVP, GM, Precision Oncology) sold a total of 929 shares of the company’s common stock. The trade occurred on Oct 08 ’24 and was made at $70.00 per share for $65030.0. Following the transaction, the insider now directly holds 12758.0 shares of the EXAS stock.
Still, SEC filings show that on Oct 08 ’24, Baranick Brian (Officer) Proposed Sale 929 shares at an average price of $70.00 for $65030.0. The insider now directly holds shares of Exact Sciences Corp (EXAS).
